Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Other Operating Expenses (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Other Operating Expenses data on record, last reported at $9.3 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 0.88% year-over-year to $9.3 million; the TTM value through Oct 2025 reached $37.4 million, up 1.05%, while the annual FY2025 figure was $36.2 million, 1.82% down from the prior year.
  • Other Operating Expenses reached $9.3 million in Q4 2025 per CSBR's latest filing, down from $9.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $10.0 million in Q2 2023 and bottomed at $6.1 million in Q1 2021.
  • Average Other Operating Expenses over 5 years is $8.7 million, with a median of $8.9 million recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 30.09% in 2022, then decreased 12.68% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $7.2 million in 2021, then increased by 26.13% to $9.1 million in 2022, then decreased by 7.98% to $8.4 million in 2023, then rose by 9.1% to $9.2 million in 2024, then rose by 0.88% to $9.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $9.3 million in Q4 2025, $9.9 million in Q3 2025, and $9.9 million in Q2 2025.